Hung Says New Prostate-Cancer Drug Has `Robust’ Effects
Hung Says New Prostate-Cancer Drug Has `Robust’ Effects – June 6 (Bloomberg) — David Hung, chief executive officer of Medivation Inc., talks about treatments for prostate cancer and Alzheimer’s disease and the outl…